|
1
|
Petersen PE: Oral cancer prevention and
control-the approach of the World Health Organization. Oral Oncol.
45:454–460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Petersen PE: World Health Organization
global policy for improvement of oral health-World Health Assembly
2007. Int Dent J. 58:115–121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marthaler TM and Petersen PE: Salt
fluoridation-an alternative in automatic prevention of dental
caries. Int Dent J. 55:351–358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Petersen PE: Tobacco and oral health-the
role of the World Health Organization. Oral Health Prev Dent.
1:309–315. 2003.PubMed/NCBI
|
|
5
|
Petersen PE, Bourgeois D, Bratthall D and
Ogawa H: Oral health information systems-towards measuring progress
in oral health promotion and disease prevention. Bull World Health
Organ. 83:686–693. 2005.PubMed/NCBI
|
|
6
|
Moynihan P and Petersen PE: Diet,
nutrition and the prevention of dental diseases. Public Health
Nutr. 7:201–226. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moynihan PJ: The role of diet and
nutrition in the etiology and prevention of oral diseases. Bull
World Health Organ. 83:694–699. 2005.PubMed/NCBI
|
|
8
|
Oral Health Worldwide, . A report by FDI
World Dental Federation. FDI World Dental Federation; Geneva:
2014
|
|
9
|
Nagpal M and Sood S: Role of curcumin in
systemic and oral health: An overview. J Nat Sci Biol Med. 4:3–7.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Elattar TM and Virji AS: The inhibitory
effect of curcumin, genistein, quercetin and cisplatin on the
growth of oral cancer cells in vitro. Anticancer Res. 20:1733–1738.
2000.PubMed/NCBI
|
|
11
|
Ramshankar V and Krishnamurthy A:
Chemoprevention of oral cancer: Green tea experience. J Nat Sci
Biol Med. 5:3–7. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Duan J, Yue W, E J, Malhotra J, Lu SE, Gu
J, Xu F and Tan XL: In vitro comparative studies of resveratrol and
triacetylresveratrol on cell proliferation, apoptosis, and STAT3
and NFκB signaling in pancreatic cancer cells. Sci Rep.
6:316722016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tao W, Xu X, Wang X, Li B, Wang Y, Li Y
and Yang L: Network pharmacology-based prediction of the active
ingredients and potential targets of Chinese herbal Radix Curcumae
formula for application to cardiovascular disease. J
Ethnopharmacol. 145:1–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang M, Lu C, Chen G, Xiao C, Zha Q, Niu
X, Chen S and Lu A: Understanding the molecular mechanism of
interventions in treating rheumatoid arthritis patients with
corresponding traditional Chinese medicine patterns based on
bioinformatics approach. Evid Based Complement Alternat Med.
2012:1294522012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li S and Zhang B: Traditional Chinese
medicine network pharmacology: Theory, methodology and application.
Chin J Nat Med. 11:110–120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aggarwal BB, Bhardwaj A, Aggarwal RS,
Seeram NP, Shishodia S and Takada Y: Role of resveratrol in
prevention and therapy of cancer: Preclinical and clinical studies.
Anticancer Res. 24:2783–2840. 2004.PubMed/NCBI
|
|
17
|
Pervaiz S and Holme AL: Resveratrol: Its
biologic targets and functional activity. Antioxid Redox Signal.
11:2851–2897. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harikumar KB and Aggarwal BB: Resveratrol:
A multitargeted agent for age-associated chronic diseases. Cell
Cycle. 7:1020–1035. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Athar M, Back JH, Kopelovich L, Bickers DR
and Kim AL: Multiple molecular targets of resveratrol:
Anti-carcinogenic mechanisms. Arch Biochem Biophys. 486:95–102.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kerem Z, Chetrit D, Shoseyov O and
Regev-Shoshani G: Protection of lipids from oxidation by
epicatechin, trans-resveratrol, and gallic and caffeic acids in
intestinal model systems. J Agric Food Chem. 54:10288–10293. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Murias M, Handler N, Erker T, Pleban K,
Ecker G, Saiko P, Szekeres T and Jäger W: Resveratrol analogues as
selective cyclooxygenase-2 inhibitors: Synthesis and
structure-activity relationship. Bioorg Med Chem. 12:5571–5578.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gehm BD, McAndrews JM, Chien PY and
Jameson JL: Resveratrol, a polyphenolic compound found in grapes
and wine, is an agonist for the estrogen receptor. Proc Natl Acad
Sci USA. 94:pp. 14138–14143. 1997; View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kraft TE, Parisotto D, Schempp C and
Efferth T: Fighting cancer with red wine? Molecular mechanisms of
resveratrol. Crit Rev Food Sci Nutr. 49:782–799. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Benová B, Adam M, Onderková K, Královsky J
and Krajicek M: Analysis of selected stilbenes in Polygonum
cuspidatum by HPLC coupled with CoulArray detection. J Sep Sci.
31:2404–2409. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu JM, Wang ZR, Hsieh TC, Bruder JL, Zou
JG and Huang YZ: Mechanism of cardioprotection by resveratrol, a
phenolic antioxidant present in red wine (Review). Int J Mol Med.
8:3–17. 2001.PubMed/NCBI
|
|
26
|
Jung JC, Lim E, Lee Y, Kang JM, Kim H,
Jang S, Oh S and Jung M: Synthesis of novel trans-stilbene
derivatives and evaluation of their potent antioxidant and
neuroprotective effects. Eur J Med Chem. 44:3166–3174. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
King RE, Kent KD and Bomser JA:
Resveratrol reduces oxidation and proliferation of human retinal
pigment epithelial cells via extracellular signal-regulated kinase
inhibition. Chem Biol Interact. 151:143–149. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Saiko P, Szakmary A, Jaeger W and Szekeres
T: Resveratrol and its analogs: Defense against cancer, coronary
disease and neurodegenerative maladies or just a fad? Mutat Res.
658:68–94. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Szekeres T, Fritzer-Szekeres M, Saiko P
and Jäger W: Resveratrol and resveratrol
analogues-structure-activity relationship. Pharm Res. 27:1042–1048.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Szekeres T, Saiko P, Fritzer-Szekeres M,
Djavan B and Jäger W: Chemopreventive effects of resveratrol and
resveratrol derivatives. Ann N Y Acad Sci. 1215:89–95. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Piotrowska H, Kucinska M and Murias M:
Biological activity of piceatannol: Leaving the shadow of
resveratrol. Mutat Res. 750:60–82. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Petrovski G, Gurusamy N and Das DK:
Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci.
1215:22–33. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ndiaye M, Philippe C, Mukhtar H and Ahmad
N: The grape antioxidant resveratrol for skin disorders: Promise,
prospects, and challenges. Arch Biochem Biophys. 508:164–170. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Szkudelska K and Szkudelski T:
Resveratrol, obesity and diabetes. Eur J Pharmacol. 635:1–8. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wahba MG, Messiha BA and Abo-Saif AA:
Protective effects of fenofibrate and resveratrol in an aggressive
model of rheumatoid arthritis in rats. Pharm Biol. 54:1705–1715.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bastianetto S, Ménard C and Quirion R:
Neuroprotective action of resveratrol. Biochim Biophys Acta.
1852:1195–1201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Markus MA and Morris BJ: Resveratrol in
prevention and treatment of common clinical conditions of aging.
Clin Interv Aging. 3:331–339. 2008.PubMed/NCBI
|
|
38
|
Frémont L: Biological effects of
resveratrol. Life Sci. 66:663–673. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang W, Tang K, Yang HR, Wen PF, Zhang P,
Wang HL and Huang WD: Distribution of resveratrol and stilbene
synthase in young grape plants (Vitis vinifera L. cv. Cabernet
Sauvignon) and the effect of UV-C on its accumulation. Plant
Physiol Biochem. 48:142–152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Soleas GJ, Diamandis EP and Goldberg DM:
Resveratrol: A molecule whose time has come? And gone? Clin
Biochem. 30:91–113. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Vastano BC, Chen Y, Zhu N, Ho CT, Zhou Z
and Rosen RT: Isolation and identification of stilbenes in two
varieties of Polygonum cuspidatum. J Agric Food Chem. 48:253–256.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hathway DE and Seakins JW:
Hydroxystilbenes of Eucalyptus wandoo. Biochem J. 72:369–374. 1959.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rolfs CH and Kindl H: Stilbene synthase
and chalcone synthase: Two different constitutive enzymes in
cultured cells of Picea excelsa. Plant Physiol. 75:489–492. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
King RE, Bomser JA and Min DB: Bioactivity
of resveratrol. Comprehensive Reviews in Food Science and Food
Safety. 5:65–70. 2006. View Article : Google Scholar
|
|
45
|
Takaoka MJ: The phenolic substances of
white hellebore (Veratrum grandiflorum Loes. fil.). J Faculty Sci.
3:1–16. 1940.
|
|
46
|
Baur JA and Sinclair DA: Therapeutic
potential of resveratrol: The in vivo evidence. Nat Rev Drug
Discov. 5:493–506. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Langcake P and Pryce RJ: A new class of
phytoalexins from grapevines. Experientia. 33:151–152. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Renaud S and de Lorgeril M: Wine, alcohol,
platelets, and the French paradox for coronary heart disease.
Lancet. 339:1523–1526. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Counet C, Callemien D and Collin S:
Chocolate and cocoa: New sources of trans-resveratrol and
trans-piceid. Food Chemistry. 98:649–657. 2006. View Article : Google Scholar
|
|
50
|
Wang Y, Catana F, Yang Y, Roderick R and
van Breemen RB: An LC-MS method for analyzing total resveratrol in
grape juice, cranberry juice, and in wine. J Agric Food Chem.
50:431–435. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Siemann EH and Creasy LL: Concentration of
the Phytoalexin resveratrol in wine. Am J Enol Vitic. 43:49–52.
1992.
|
|
52
|
Guerrero RF, Garcia-Parrilla MC, Puertas B
and Cantos-Villar E: Wine, resveratrol and health: A review. Nat
Prod Commun. 4:635–658. 2009.PubMed/NCBI
|
|
53
|
Stervbo U, Vang O and Bonnesen C: A review
of the content of the putative chemopreventive phytoalexin
resveratrol in red wine. Food Chemistry. 101:449–457. 2007.
View Article : Google Scholar
|
|
54
|
Figueiras TS, Neves-Petersen MT and
Petersen SB: Activation energy of light induced isomerization of
resveratrol. J Fluoresc. 21:1897–1906. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cai YJ, Wei QY, Fang JG, Yang L, Liu ZL,
Wyche JH and Han Z: The 3,4-dihydroxyl groups are important for
trans-resveratrol analogs to exhibit enhanced antioxidant and
apoptotic activities. Anticancer Res. 24:999–1002. 2004.PubMed/NCBI
|
|
56
|
Wieder T, Prokop A, Bagci B, Essmann F,
Bernicke D, Schulze-Osthoff K, Dörken B, Schmalz HG, Daniel PT and
Henze G: Piceatannol, a hydroxylated analog of the chemopreventive
agent resveratrol, is a potent inducer of apoptosis in the lymphoma
cell line BJAB and in primary, leukemic lymphoblasts. Leukemia.
15:1735–1742. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yang T, Wang L, Zhu M, Zhang L and Yan L:
Properties and molecular mechanisms of resveratrol: A review.
Pharmazie. 70:501–506. 2015.PubMed/NCBI
|
|
58
|
Biasutto L, Marotta E, Bradaschia A,
Fallica M, Mattarei A, Garbisa S, Zoratti M and Paradisi C: Soluble
polyphenols: Synthesis and bioavailability of
3,4′,5-tri(alpha-D-glucose-3-O-succinyl) resveratrol. Bioorg Med
Chem Lett. 19:6721–6724. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ratnam DV, Ankola DD, Bhardwaj V, Sahana
DK and Kumar MN: Role of antioxidants in prophylaxis and therapy: A
pharmaceutical perspective. J Control Release. 113:189–207. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lin YL, Chang HC, Chen TL, Chang JH, Chiu
WT, Lin JW and Chen RM: Resveratrol protects against oxidized
LDL-induced breakage of the blood-brain barrier by lessening
disruption of tight junctions and apoptotic insults to mouse
cerebrovascular endothelial cells. J Nutr. 140:2187–2192. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Du QH, Peng C and Zhang H: Polydatin: A
review of pharmacology and pharmacokinetics. Pharm Biol.
51:1347–1354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Plou FJ, Segura AGd and Ballesteros A:
Application of Glycosidases and Transglycosidases in the synthesis
of oligosaccharidesIndustrial enzymes: Structure, function and
applications. Polaina J and MacCabe AP: Springer; Netherlands,
Dordrecht: pp. 141–157. 2007, View Article : Google Scholar
|
|
63
|
Bertrand A, Morel S, Lefoulon F, Rolland
Y, Monsan P and Remaud-Simeon M: Leuconostoc mesenteroides
glucansucrase synthesis of flavonoid glucosides by acceptor
reactions in aqueous-organic solvents. Carbohydr Res. 341:855–863.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Cichewicz RH and Kouzi SA:
Biotransformation of resveratrol to piceid by Bacillus cereus. J
Nat Prod. 61:1313–1314. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Baek SJ, Wilson LC and Eling TE:
Resveratrol enhances the expression of non-steroidal
anti-inflammatory drug-activated gene (NAG-1) by increasing the
expression of p53. Carcinogenesis. 23:425–434. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Aziz MH, Kumar R and Ahmad N: Cancer
chemoprevention by resveratrol: In vitro and in vivo studies and
the underlying mechanisms (review). Int J Oncol. 23:17–28.
2003.PubMed/NCBI
|
|
67
|
Walle T, Hsieh F, DeLegge MH, Oatis JE Jr
and Walle UK: High absorption but very low bioavailability of oral
resveratrol in humans. Drug Metab Dispos. 32:1377–1382. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Marier JF, Vachon P, Gritsas A, Zhang J,
Moreau JP and Ducharme MP: Metabolism and disposition of
resveratrol in rats: Extent of absorption, glucuronidation, and
enterohepatic recirculation evidenced by a linked-rat model. J
Pharmacol Exp Ther. 302:369–373. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Belguendouz L, Fremont L and Linard A:
Resveratrol inhibits metal ion-dependent and independent
peroxidation of porcine low-density lipoproteins. Biochem
Pharmacol. 53:1347–1355. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Jannin B, Menzel M, Berlot JP, Delmas D,
Lancon A and Latruffe N: Transport of resveratrol, a cancer
chemopreventive agent, to cellular targets: Plasmatic protein
binding and cell uptake. Biochem Pharmacol. 68:1113–1118. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Lançon A, Delmas D, Osman H, Thénot JP,
Jannin B and Latruffe N: Human hepatic cell uptake of resveratrol:
Involvement of both passive diffusion and carrier-mediated process.
Biochem Biophys Res Commun. 316:1132–1137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Lucas R, Alcantara D and Morales JC: A
concise synthesis of glucuronide metabolites of urolithin-B,
resveratrol, and hydroxytyrosol. Carbohydr Res. 344:1340–1346.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Bertelli AA, Giovannini L, Stradi R,
Bertelli A and Tillement JP: Plasma, urine and tissue levels of
trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after
short-term or prolonged administration of red wine to rats. Int J
Tissue React. 18:67–71. 1996.PubMed/NCBI
|
|
74
|
El Mohsen MA, Marks J, Kuhnle G, Moore K,
Debnam E, Srai S Kaila, Rice-Evans C and Spencer JP: Absorption,
tissue distribution and excretion of pelargonidin and its
metabolites following oral administration to rats. Br J Nutr.
95:51–58. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Vitrac X, Desmoulière A, Brouillaud B,
Krisa S, Deffieux G, Barthe N, Rosenbaum J and Mérillon JM:
Distribution of [14C]-trans-resveratrol, a cancer chemopreventive
polyphenol, in mouse tissues after oral administration. Life Sci.
72:2219–2233. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
de Santi C, Pietrabissa A, Spisni R, Mosca
F and Pacifici GM: Sulphation of resveratrol, a natural product
present in grapes and wine, in the human liver and duodenum.
Xenobiotica. 30:609–617. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Koga CC, Andrade JE, Ferruzzi MG and Lee
Y: Stability of trans-resveratrol encapsulated in a protein matrix
produced using spray drying to UV light stress and simulated
gastro-intestinal digestion. J Food Sci. 81:C292–C300. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Teskac K and Kristl J: The evidence for
solid lipid nanoparticles mediated cell uptake of resveratrol. Int
J Pharm. 390:61–69. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Nam JB, Ryu JH, Kim JW, Chang IS and Suh
KD: Stabilization of resveratrol immobilized in monodisperse
cyano-functionalized porous polymeric microspheres. Polymer.
46:8956–8963. 2005. View Article : Google Scholar
|
|
80
|
Shi G, Rao L, Yu H, Xiang H, Yang H and Ji
R: Stabilization and encapsulation of photosensitive resveratrol
within yeast cell. Int J Pharm. 349:83–93. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Kesisoglou F, Panmai S and Wu Y:
Nanosizing-oral formulation development and biopharmaceutical
evaluation. Adv Drug Deliv Rev. 59:631–644. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Rasenack N and Müller BW: Crystal habit
and tableting behavior. Int J Pharm. 244:45–57. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Juan ME, Vinardell MP and Planas JM: The
daily oral administration of high doses of trans-resveratrol to
rats for 28 days is not harmful. J Nutr. 132:257–260.
2002.PubMed/NCBI
|
|
84
|
Leonard SS, Xia C, Jiang BH, Stinefelt B,
Klandorf H, Harris GK and Shi X: Resveratrol scavenges reactive
oxygen species and effects radical-induced cellular responses.
Biochem Biophys Res Commun. 309:1017–1026. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Halliwell B and Gutteridge JM: Role of
free radicals and catalytic metal ions in human disease: An
overview. Methods Enzymol. 186:1–85. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Rizvi SI and Pandey KB: Activation of the
erythrocyte plasma membrane redox system by resveratrol: A possible
mechanism for antioxidant properties. Pharmacol Rep. 62:726–732.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Das S and Das DK: Anti-inflammatory
responses of resveratrol. Inflamm Allergy Drug Targets. 6:168–173.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Birben E, Sahiner UM, Sackesen C, Erzurum
S and Kalayci O: Oxidative stress and antioxidant defense. World
Allergy Organ J. 5:9–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Simon HU, Haj-Yehia A and Levi-Schaffer F:
Role of reactive oxygen species (ROS) in apoptosis induction.
Apoptosis. 5:415–418. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kim CH, Jeon HM, Lee SY, Jeong EK, Ju MK,
Park BJ, Park HG, Lim SC, Han SI and Kang HS: Role of reactive
oxygen species-dependent protein aggregation in metabolic
stress-induced necrosis. Int J Oncol. 37:97–102. 2010.PubMed/NCBI
|
|
91
|
la Lastra CA and Villegas I: Resveratrol
as an antioxidant and pro-oxidant agent: Mechanisms and clinical
implications. Biochem Soc Trans. 35:1156–1160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Azmi AS, Bhat SH, Hanif S and Hadi SM:
Plant polyphenols mobilize endogenous copper in human peripheral
lymphocytes leading to oxidative DNA breakage: A putative mechanism
for anticancer properties. FEBS Lett. 580:533–538. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Jang M and Pezzuto JM: Cancer
chemopreventive activity of resveratrol. Drugs Exp Clin Res.
25:65–77. 1999.PubMed/NCBI
|
|
94
|
Cao Z and Li Y: Potent induction of
cellular antioxidants and phase 2 enzymes by resveratrol in
cardiomyocytes: Protection against oxidative and electrophilic
injury. Eur J Pharmacol. 489:39–48. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Yen GC, Duh PD and Lin CW: Effects of
resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced
oxidative DNA damage in human lymphocytes. Free Radic Res.
37:509–514. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Melov S: Therapeutics against
mitochondrial oxidative stress in animal models of aging. Ann N Y
Acad Sci. 959:330–340. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Ates O, Cayli SR, Yucel N, Altinoz E,
Kocak A, Durak MA, Turkoz Y and Yologlu S: Central nervous system
protection by resveratrol in streptozotocin-induced diabetic rats.
J Clin Neurosci. 14:256–260. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Belguendouz L, Frémont L and Gozzelino MT:
Interaction of transresveratrol with plasma lipoproteins. Biochem
Pharmacol. 55:811–816. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Rotondo S, Rajtar G, Manarini S, Celardo
A, Rotillo D, De Gaetano G, Evangelista V and Cerletti C: Effect of
trans-resveratrol, a natural polyphenolic compound, on human
polymorphonuclear leukocyte function. Br J Pharmacol.
123:1691–1699. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
West JD and Marnett LJ: Endogenous
reactive intermediates as modulators of cell signaling and cell
death. Chem Res Toxicol. 19:173–194. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Lee HS, Kim HN, Jung MH and Choi JY:
Electrically evoked potentials recorded in a patient with auditory
neuropathy. Cochlear Implants Int. 5 Suppl 1:S2312004. View Article : Google Scholar
|
|
102
|
Rizvi SI and Maurya PK: Alterations in
antioxidant enzymes during aging in humans. Mol Biotechnol.
37:58–61. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Wenzel U, Nickel A and Daniel H: Increased
mitochondrial palmitoylcarnitine/carnitine countertransport by
flavone causes oxidative stress and apoptosis in colon cancer
cells. Cell Mol Life Sci. 62:3100–3105. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Guo R, Su Y, Liu B, Li S, Zhou S and Xu Y:
Resveratrol suppresses oxidised low-density lipoprotein-induced
macrophage apoptosis through inhibition of intracellular reactive
oxygen species generation, LOX-1, and the p38 MAPK pathway. Cell
Physiol Biochem. 34:603–616. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Dani C, Bonatto D, Salvador M, Pereira MD,
Henriques JA and Eleutherio E: Antioxidant protection of
resveratrol and catechin in Saccharomyces cerevisiae. J Agric Food
Chem. 56:4268–4272. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Naylor AJ Dirks: Cellular effects of
resveratrol in skeletal muscle. Life Sci. 84:637–640. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Pandey KB and Rizvi SI: Protective effect
of resveratrol on formation of membrane protein carbonyls and lipid
peroxidation in erythrocytes subjected to oxidative stress. Appl
Physiol Nutr Metab. 34:1093–1097. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Pandey KB and Rizvi SI: Plant polyphenols
as dietary antioxidants in human health and disease. Oxid Med Cell
Longev. 2:270–278. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Rizvi SI, Jha R and Pandey KB: Activation
of erythrocyte plasma membrane redox system provides a useful
method to evaluate antioxidant potential of plant polyphenols.
Methods Mol Biol. 594:341–348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Goldberg DM, Yan J and Soleas GJ:
Absorption of three wine-related polyphenols in three different
matrices by healthy subjects. Clin Biochem. 36:79–87. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Perrone D, Ardito F, Giannatempo G,
Dioguardi M, Troiano G, Lo Russo L, De Lillo A, Laino L and Lo
Muzio L: Biological and therapeutic activities, and anticancer
properties of curcumin. Exp Ther Med. 10:1615–1623. 2015.PubMed/NCBI
|
|
112
|
Maioli E, Torricelli C and Valacchi G:
Rottlerin and cancer: Novel evidence and mechanisms. Scientific
World Journal. 2012:3508262012. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Russo M, Russo GL, Daglia M, Kasi PD, Ravi
S, Nabavi SF and Nabavi SM: Understanding genistein in cancer: The
‘good’ and the ‘bad’ effects: A review. Food Chem. 196:589–600.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Brito AF, Ribeiro M, Abrantes AM, Pires
AS, Teixo RJ, Tralhão JG and Botelho MF: Quercetin in cancer
treatment, alone or in combination with conventional therapeutics?
Curr Med Chem. 22:3025–3039. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Zhao X and Zhang J: Mechanisms for
quercetin in prevention of lung cancer cell growth and metastasis.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 40:592–597. 2015.(In Chinese).
PubMed/NCBI
|
|
116
|
Feitelson MA, Arzumanyan A, Kulathinal RJ,
Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML,
Nawroth R, Sanchez-Garcia I, et al: Sustained proliferation in
cancer: Mechanisms and novel therapeutic targets. Semin Cancer
Biol. 35 Suppl:S25–S54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Yu XD, Yang JL, Zhang WL and Liu DX:
Resveratrol inhibits oral squamous cell carcinoma through induction
of apoptosis and G2/M phase cell cycle arrest. Tumour Biol.
37:2871–2877. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Ray JG, Ranganathan K and Chattopadhyay A:
Malignant transformation of oral submucous fibrosis: Overview of
histopathological aspects. Oral Surg Oral Med Oral Pathol Oral
Radiol. 122:200–209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Sharma M and Radhakrishnan R: Limited
mouth opening in oral submucous fibrosis: Reasons, ramifications,
and remedies. J Oral Pathol Med. Oct 15–2016.(Epub ahead of print).
View Article : Google Scholar
|
|
120
|
Chang YC, Lin CW, Yu CC, Wang BY, Huang
YH, Hsieh YC, Kuo YL and Chang WW: Resveratrol suppresses
myofibroblast activity of human buccal mucosal fibroblasts through
the epigenetic inhibition of ZEB1 expression. Oncotarget.
7:12137–12149. 2016.PubMed/NCBI
|
|
121
|
Mohan A, Narayanan S, Balasubramanian G,
Sethuraman S and Krishnan UM: Dual drug loaded nanoliposomal
chemotherapy: A promising strategy for treatment of head and neck
squamous cell carcinoma. Eur J Pharm Biopharm. 99:73–83. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
ElAttar TM and Virji AS: Modulating effect
of resveratrol and quercetin on oral cancer cell growth and
proliferation. Anticancer Drugs. 10:187–193. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Lin FY, Hsieh YH, Yang SF, Chen CT, Tang
CH, Chou MY, Chuang YT, Lin CW and Chen MK: Resveratrol suppresses
TPA-induced matrix metalloproteinase-9 expression through the
inhibition of MAPK pathways in oral cancer cells. J Oral Pathol
Med. 44:699–706. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Masuelli L, Di Stefano E, Fantini M,
Mattera R, Benvenuto M, Marzocchella L, Sacchetti P, Focaccetti C,
Bernardini R, Tresoldi I, et al: Resveratrol potentiates the in
vitro and in vivo anti-tumoral effects of curcumin in head and neck
carcinomas. Oncotarget. 5:10745–10762. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Shan Z, Yang G, Xiang W, Pei-Jun W and Bin
Z: Effects of resveratrol on oral squamous cell carcinoma (OSCC)
cells in vitro. J Cancer Res Clin Oncol. 140:371–374. 2014.
View Article : Google Scholar : PubMed/NCBI
|
